34962611000001109: Co-amoxiclav 250mg/125mg tablets (Bristol Laboratories Ltd) (product)

SNOMED CT Concept\Pharmaceutical / biologic product\...

\UK product\Actual medicinal product\Co-amoxiclav 250mg/125mg tablets (Bristol Laboratories Ltd)
\UK product\Virtual medicinal product\Co-amoxiclav 250mg/125mg tablets\Co-amoxiclav 250mg/125mg tablets (Bristol Laboratories Ltd)
\UK product\Virtual therapeutic moiety\Co-amoxiclav\Co-amoxiclav 250mg/125mg tablets\Co-amoxiclav 250mg/125mg tablets (Bristol Laboratories Ltd)

\Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing beta-lactam\Product containing penicillin (product)\Medicinal product containing penicillin and acting as antibacterial agent (product)\Co-amoxiclav\Co-amoxiclav 250mg/125mg tablets\Co-amoxiclav 250mg/125mg tablets (Bristol Laboratories Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing beta-lactam\Medicinal product containing beta-lactam and acting as antibacterial agent (product)\Medicinal product containing penicillin and acting as antibacterial agent (product)\Co-amoxiclav\Co-amoxiclav 250mg/125mg tablets\Co-amoxiclav 250mg/125mg tablets (Bristol Laboratories Ltd)
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antiinfective agent (product)\Medicinal product acting as antibacterial agent (product)\Medicinal product containing beta-lactam and acting as antibacterial agent (product)\Medicinal product containing penicillin and acting as antibacterial agent (product)\Co-amoxiclav\Co-amoxiclav 250mg/125mg tablets\Co-amoxiclav 250mg/125mg tablets (Bristol Laboratories Ltd)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 27-Dec 2017. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module

105997701000001118 Co-amoxiclav 250mg/125mg tablets (Bristol Laboratories Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

105997801000001110 Co-amoxiclav 250mg/125mg tablets (Bristol Laboratories Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Co-amoxiclav 250mg/125mg tablets (Bristol Laboratories Ltd)	Has excipient	Excipient not declared	true	Inferred relationship	Existential restriction modifier
Co-amoxiclav 250mg/125mg tablets (Bristol Laboratories Ltd)	Has NHS dm+d (dictionary of medicines and devices) controlled drug category	Controlled drug category No Controlled Drug Status	true	Inferred relationship	Existential restriction modifier
Co-amoxiclav 250mg/125mg tablets (Bristol Laboratories Ltd)	Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator	NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none	true	Inferred relationship	Existential restriction modifier
Co-amoxiclav 250mg/125mg tablets (Bristol Laboratories Ltd)	Is a	Co-amoxiclav 250mg/125mg tablets	true	Inferred relationship	Existential restriction modifier
Co-amoxiclav 250mg/125mg tablets (Bristol Laboratories Ltd)	Is a	Co-amoxiclav 250mg/125mg tablets	false	Inferred relationship	Existential restriction modifier
Co-amoxiclav 250mg/125mg tablets (Bristol Laboratories Ltd)	Is a	Product containing precisely amoxicillin 250 milligram and clavulanic acid (as clavulanate potassium) 125 milligram/1 each conventional release oral tablet	false	Inferred relationship	Existential restriction modifier
Co-amoxiclav 250mg/125mg tablets (Bristol Laboratories Ltd)	Has active ingredient	Amoxicillin	false	Inferred relationship	Existential restriction modifier	2
Co-amoxiclav 250mg/125mg tablets (Bristol Laboratories Ltd)	Has active ingredient	Clavulanate potassium	false	Inferred relationship	Existential restriction modifier	1
Co-amoxiclav 250mg/125mg tablets (Bristol Laboratories Ltd)	Has manufactured dose form	Tablet	false	Inferred relationship	Existential restriction modifier
Co-amoxiclav 250mg/125mg tablets (Bristol Laboratories Ltd)	Has manufactured dose form	Conventional release oral tablet	true	Inferred relationship	Existential restriction modifier
Co-amoxiclav 250mg/125mg tablets (Bristol Laboratories Ltd)	Has basis of strength substance	Amoxicillin	true	Inferred relationship	Existential restriction modifier	2
Co-amoxiclav 250mg/125mg tablets (Bristol Laboratories Ltd)	Has basis of strength substance	Clavulanic acid	true	Inferred relationship	Existential restriction modifier	1
Co-amoxiclav 250mg/125mg tablets (Bristol Laboratories Ltd)	Has presentation strength numerator value	125	false	Inferred relationship	Existential restriction modifier	1
Co-amoxiclav 250mg/125mg tablets (Bristol Laboratories Ltd)	Has presentation strength numerator value	250	false	Inferred relationship	Existential restriction modifier	2
Co-amoxiclav 250mg/125mg tablets (Bristol Laboratories Ltd)	Has presentation strength numerator unit	milligram	true	Inferred relationship	Existential restriction modifier	1
Co-amoxiclav 250mg/125mg tablets (Bristol Laboratories Ltd)	Has presentation strength numerator unit	milligram	true	Inferred relationship	Existential restriction modifier	2
Co-amoxiclav 250mg/125mg tablets (Bristol Laboratories Ltd)	Has presentation strength denominator value	1	false	Inferred relationship	Existential restriction modifier	1
Co-amoxiclav 250mg/125mg tablets (Bristol Laboratories Ltd)	Has presentation strength denominator value	1	false	Inferred relationship	Existential restriction modifier	2
Co-amoxiclav 250mg/125mg tablets (Bristol Laboratories Ltd)	Has presentation strength denominator unit	Tablet	true	Inferred relationship	Existential restriction modifier	1
Co-amoxiclav 250mg/125mg tablets (Bristol Laboratories Ltd)	Has presentation strength denominator unit	Tablet	true	Inferred relationship	Existential restriction modifier	2
Co-amoxiclav 250mg/125mg tablets (Bristol Laboratories Ltd)	VMP prescribing status (attribute)	VMP valid as a prescribable product	true	Inferred relationship	Existential restriction modifier
Co-amoxiclav 250mg/125mg tablets (Bristol Laboratories Ltd)	VMP non-availability indicator	Available	true	Inferred relationship	Existential restriction modifier
Co-amoxiclav 250mg/125mg tablets (Bristol Laboratories Ltd)	Has specific active ingredient	Amoxicillin trihydrate	true	Inferred relationship	Existential restriction modifier
Co-amoxiclav 250mg/125mg tablets (Bristol Laboratories Ltd)	Has specific active ingredient	Clavulanate potassium	true	Inferred relationship	Existential restriction modifier
Co-amoxiclav 250mg/125mg tablets (Bristol Laboratories Ltd)	Has dispensed dose form	Tablet	true	Inferred relationship	Existential restriction modifier
Co-amoxiclav 250mg/125mg tablets (Bristol Laboratories Ltd)	Has NHS dm+d (dictionary of medicines and devices) basis of strength substance	Amoxicillin	true	Inferred relationship	Existential restriction modifier
Co-amoxiclav 250mg/125mg tablets (Bristol Laboratories Ltd)	Has NHS dm+d (dictionary of medicines and devices) basis of strength substance	Clavulanic acid	true	Inferred relationship	Existential restriction modifier
Co-amoxiclav 250mg/125mg tablets (Bristol Laboratories Ltd)	Has excipient	Butylated hydroxytoluene	false	Inferred relationship	Existential restriction modifier
Co-amoxiclav 250mg/125mg tablets (Bristol Laboratories Ltd)	Is a	Actual medicinal product	true	Inferred relationship	Existential restriction modifier

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Co-amoxiclav 250mg/125mg tablets (Bristol Laboratories Ltd) 21 tablet 3 x 7 tablets	Has AMP	True	Co-amoxiclav 250mg/125mg tablets (Bristol Laboratories Ltd)	Inferred relationship	Existential restriction modifier

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
105997701000001118	Co-amoxiclav 250mg/125mg tablets (Bristol Laboratories Ltd) (product)	en	Fully specified name	Active	Entire term case sensitive	SNOMED CT United Kingdom drug extension module
105997801000001110	Co-amoxiclav 250mg/125mg tablets (Bristol Laboratories Ltd)	en	Synonym	Active	Entire term case sensitive	SNOMED CT United Kingdom drug extension module